

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axonemal dynein complex assembly (GO:0070286) | 9.48587234 |
| 2 | neurofilament cytoskeleton organization (GO:0060052) | 9.22322458 |
| 3 | cilium or flagellum-dependent cell motility (GO:0001539) | 8.72961663 |
| 4 | cilium movement (GO:0003341) | 7.89088031 |
| 5 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 7.87648192 |
| 6 | epithelial cilium movement (GO:0003351) | 7.54778204 |
| 7 | axoneme assembly (GO:0035082) | 6.70864184 |
| 8 | motile cilium assembly (GO:0044458) | 6.53776225 |
| 9 | negative regulation of dendrite morphogenesis (GO:0050774) | 6.49061920 |
| 10 | peripheral nervous system neuron development (GO:0048935) | 6.45794063 |
| 11 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 5.77678532 |
| 12 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 5.77678532 |
| 13 | detection of temperature stimulus (GO:0016048) | 5.77336417 |
| 14 | regulation of relaxation of muscle (GO:1901077) | 5.39480178 |
| 15 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 5.30167944 |
| 16 | neuronal action potential propagation (GO:0019227) | 5.22161516 |
| 17 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.76046562 |
| 18 | regulation of cilium movement (GO:0003352) | 4.75451143 |
| 19 | protein localization to cilium (GO:0061512) | 4.67866916 |
| 20 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.55756474 |
| 21 | cell migration in hindbrain (GO:0021535) | 4.54026589 |
| 22 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.53869105 |
| 23 | intermediate filament organization (GO:0045109) | 4.53277887 |
| 24 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 4.52160255 |
| 25 | regulation of cell communication by electrical coupling (GO:0010649) | 4.44261058 |
| 26 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.43329733 |
| 27 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.41144102 |
| 28 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.38011810 |
| 29 | plasma membrane repair (GO:0001778) | 4.30331476 |
| 30 | cilium organization (GO:0044782) | 4.26615885 |
| 31 | left/right axis specification (GO:0070986) | 4.22205033 |
| 32 | negative regulation of dendrite development (GO:2000171) | 4.20560546 |
| 33 | cilium assembly (GO:0042384) | 4.13515707 |
| 34 | intraciliary transport (GO:0042073) | 4.11544746 |
| 35 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.11387971 |
| 36 | cellular ketone body metabolic process (GO:0046950) | 4.07336704 |
| 37 | membrane depolarization during action potential (GO:0086010) | 4.06571149 |
| 38 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.05759943 |
| 39 | neuronal action potential (GO:0019228) | 4.01427019 |
| 40 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.00465380 |
| 41 | regulation of platelet aggregation (GO:0090330) | 3.92923488 |
| 42 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.87345825 |
| 43 | ketone body metabolic process (GO:1902224) | 3.75926565 |
| 44 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.73560570 |
| 45 | cell communication involved in cardiac conduction (GO:0086065) | 3.73494912 |
| 46 | regulation of glucokinase activity (GO:0033131) | 3.71366429 |
| 47 | regulation of hexokinase activity (GO:1903299) | 3.71366429 |
| 48 | microtubule bundle formation (GO:0001578) | 3.69545978 |
| 49 | regulation of membrane repolarization (GO:0060306) | 3.67454828 |
| 50 | cilium morphogenesis (GO:0060271) | 3.64682605 |
| 51 | left/right pattern formation (GO:0060972) | 3.58287510 |
| 52 | primary alcohol catabolic process (GO:0034310) | 3.46406462 |
| 53 | cellular component assembly involved in morphogenesis (GO:0010927) | 3.41187805 |
| 54 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.39612197 |
| 55 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.37057841 |
| 56 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.35296743 |
| 57 | L-fucose metabolic process (GO:0042354) | 3.35037246 |
| 58 | L-fucose catabolic process (GO:0042355) | 3.35037246 |
| 59 | fucose catabolic process (GO:0019317) | 3.35037246 |
| 60 | mitochondrion transport along microtubule (GO:0047497) | 3.32514330 |
| 61 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.32514330 |
| 62 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.29288647 |
| 63 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.26364766 |
| 64 | ventricular system development (GO:0021591) | 3.23942297 |
| 65 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.20740263 |
| 66 | establishment of mitochondrion localization (GO:0051654) | 3.19887861 |
| 67 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.19246773 |
| 68 | cornea development in camera-type eye (GO:0061303) | 3.18240443 |
| 69 | regulation of actin filament-based movement (GO:1903115) | 3.18190819 |
| 70 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.16844065 |
| 71 | one-carbon compound transport (GO:0019755) | 3.14101526 |
| 72 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.13129421 |
| 73 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.13129421 |
| 74 | photoreceptor cell maintenance (GO:0045494) | 3.12260007 |
| 75 | inositol phosphate catabolic process (GO:0071545) | 3.11163131 |
| 76 | negative regulation of muscle hypertrophy (GO:0014741) | 3.10779907 |
| 77 | sarcomere organization (GO:0045214) | 3.10272691 |
| 78 | axon development (GO:0061564) | 3.09872790 |
| 79 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.09299735 |
| 80 | vitamin transmembrane transport (GO:0035461) | 3.09191883 |
| 81 | serotonin receptor signaling pathway (GO:0007210) | 3.09075926 |
| 82 | retinal cone cell development (GO:0046549) | 3.06238232 |
| 83 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.04291765 |
| 84 | regulation of cardiac muscle contraction (GO:0055117) | 3.04282844 |
| 85 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.03645910 |
| 86 | detection of light stimulus involved in visual perception (GO:0050908) | 3.03645910 |
| 87 | terpenoid biosynthetic process (GO:0016114) | 3.02652234 |
| 88 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.02185575 |
| 89 | behavioral response to pain (GO:0048266) | 3.02160487 |
| 90 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.01567017 |
| 91 | cell communication by electrical coupling (GO:0010644) | 2.99410291 |
| 92 | heart contraction (GO:0060047) | 2.98479724 |
| 93 | heart process (GO:0003015) | 2.98479724 |
| 94 | intermediate filament-based process (GO:0045103) | 2.98359737 |
| 95 | cardiac muscle contraction (GO:0060048) | 2.97965551 |
| 96 | action potential (GO:0001508) | 2.97790232 |
| 97 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.96542989 |
| 98 | response to acidic pH (GO:0010447) | 2.96424705 |
| 99 | aldehyde catabolic process (GO:0046185) | 2.96360246 |
| 100 | regulation of striated muscle contraction (GO:0006942) | 2.95978183 |
| 101 | neuron fate specification (GO:0048665) | 2.94851924 |
| 102 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.94552672 |
| 103 | regulation of microtubule-based movement (GO:0060632) | 2.94283146 |
| 104 | respiratory chain complex IV assembly (GO:0008535) | 2.92497019 |
| 105 | intermediate filament cytoskeleton organization (GO:0045104) | 2.91942147 |
| 106 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.90404568 |
| 107 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.89499709 |
| 108 | response to xenobiotic stimulus (GO:0009410) | 2.89498037 |
| 109 | ethanol metabolic process (GO:0006067) | 2.88295765 |
| 110 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.88201465 |
| 111 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.85704661 |
| 112 | diterpenoid biosynthetic process (GO:0016102) | 2.85280563 |
| 113 | lung epithelium development (GO:0060428) | 2.85207321 |
| 114 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.83153581 |
| 115 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.83144763 |
| 116 | myofibril assembly (GO:0030239) | 2.83002278 |
| 117 | response to pheromone (GO:0019236) | 2.81391656 |
| 118 | nucleotide transmembrane transport (GO:1901679) | 2.81324356 |
| 119 | cellular response to nicotine (GO:0071316) | 2.81019134 |
| 120 | neural tube formation (GO:0001841) | 2.79376498 |
| 121 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.79336853 |
| 122 | organic cation transport (GO:0015695) | 2.79174770 |
| 123 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.78783515 |
| 124 | inositol phosphate dephosphorylation (GO:0046855) | 2.78783515 |
| 125 | exogenous drug catabolic process (GO:0042738) | 2.78076615 |
| 126 | cranial nerve development (GO:0021545) | 2.77189886 |
| 127 | cardiac conduction (GO:0061337) | 2.75246677 |
| 128 | cytidine metabolic process (GO:0046087) | 2.74920355 |
| 129 | cytidine catabolic process (GO:0006216) | 2.74920355 |
| 130 | cytidine deamination (GO:0009972) | 2.74920355 |
| 131 | striated muscle contraction (GO:0006941) | 2.74436507 |
| 132 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.74039724 |
| 133 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.73791919 |
| 134 | cell projection assembly (GO:0030031) | 2.73445159 |
| 135 | negative regulation of platelet activation (GO:0010544) | 2.70996357 |
| 136 | glutathione derivative metabolic process (GO:1901685) | 2.70418511 |
| 137 | glutathione derivative biosynthetic process (GO:1901687) | 2.70418511 |
| 138 | regulation of protein heterodimerization activity (GO:0043497) | 2.69673669 |
| 139 | nonmotile primary cilium assembly (GO:0035058) | 2.67445583 |
| 140 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.67313317 |
| 141 | retinoic acid metabolic process (GO:0042573) | 2.67140332 |
| 142 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.67117921 |
| 143 | mechanoreceptor differentiation (GO:0042490) | 2.66873315 |
| 144 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.66519626 |
| 145 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.65655617 |
| 146 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.65407723 |
| 147 | positive regulation of macrophage differentiation (GO:0045651) | 2.65376656 |
| 148 | isoprenoid biosynthetic process (GO:0008299) | 2.65011939 |
| 149 | neuromuscular process controlling posture (GO:0050884) | 2.63885643 |
| 150 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.63539206 |
| 151 | S-adenosylmethionine metabolic process (GO:0046500) | 2.63186852 |
| 152 | mannosylation (GO:0097502) | 2.63140921 |
| 153 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.61841657 |
| 154 | sperm motility (GO:0030317) | 2.61538343 |
| 155 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.61356631 |
| 156 | positive regulation of potassium ion transport (GO:0043268) | 2.60847869 |
| 157 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.60576815 |
| 158 | ubiquinone biosynthetic process (GO:0006744) | 2.60443114 |
| 159 | cardiac muscle cell action potential (GO:0086001) | 2.58734236 |
| 160 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.58465155 |
| 161 | negative regulation of cation channel activity (GO:2001258) | 2.58463749 |
| 162 | regulation of neuron projection regeneration (GO:0070570) | 2.58414489 |
| 163 | regulation of axon regeneration (GO:0048679) | 2.58414489 |
| 164 | regulation of cation channel activity (GO:2001257) | 2.57543070 |
| 165 | regulation of cell maturation (GO:1903429) | 2.56926560 |
| 166 | centriole assembly (GO:0098534) | 2.56847377 |
| 167 | polyol catabolic process (GO:0046174) | 2.56111225 |
| 168 | positive regulation of sodium ion transport (GO:0010765) | 2.55789514 |
| 169 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.54580491 |
| 170 | auditory receptor cell stereocilium organization (GO:0060088) | 2.53651133 |
| 171 | platelet dense granule organization (GO:0060155) | 2.53624171 |
| 172 | negative regulation of B cell mediated immunity (GO:0002713) | 2.52860010 |
| 173 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.52860010 |
| 174 | behavioral response to nicotine (GO:0035095) | 2.50807389 |
| 175 | proline transport (GO:0015824) | 2.49821578 |
| 176 | sialylation (GO:0097503) | 2.49654415 |
| 177 | glycosphingolipid biosynthetic process (GO:0006688) | 2.49607853 |
| 178 | ubiquinone metabolic process (GO:0006743) | 2.47894147 |
| 179 | microtubule-based movement (GO:0007018) | 2.47154282 |
| 180 | intra-S DNA damage checkpoint (GO:0031573) | 2.46039091 |
| 181 | peptidyl-histidine modification (GO:0018202) | 2.42094930 |
| 182 | regulation of collateral sprouting (GO:0048670) | 2.40649982 |
| 183 | GPI anchor metabolic process (GO:0006505) | 2.40464659 |
| 184 | cytochrome complex assembly (GO:0017004) | 2.40208034 |
| 185 | negative regulation of humoral immune response (GO:0002921) | 2.39536375 |
| 186 | response to nitrosative stress (GO:0051409) | 2.37891356 |
| 187 | L-methionine biosynthetic process (GO:0071265) | 2.37820860 |
| 188 | amino acid salvage (GO:0043102) | 2.37820860 |
| 189 | L-methionine salvage (GO:0071267) | 2.37820860 |
| 190 | negative regulation of protein oligomerization (GO:0032460) | 2.37747270 |
| 191 | coenzyme catabolic process (GO:0009109) | 2.35974036 |
| 192 | ethanol oxidation (GO:0006069) | 2.35542643 |
| 193 | negative regulation of neurological system process (GO:0031645) | 2.34910142 |
| 194 | quinone biosynthetic process (GO:1901663) | 2.33432761 |
| 195 | drug catabolic process (GO:0042737) | 2.33095085 |
| 196 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.32503331 |
| 197 | neurotransmitter metabolic process (GO:0042133) | 2.31619255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.30840155 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.43651613 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.40643339 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.20008810 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.93807102 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.69552679 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.66144999 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.63913435 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.54872375 |
| 10 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.51172179 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.45763706 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.27241885 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.27241885 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.26545974 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.21369358 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.20025042 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.15458064 |
| 18 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.05678115 |
| 19 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.02753555 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.01742627 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.98553841 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.98355025 |
| 23 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.97206358 |
| 24 | FUS_26573619_Chip-Seq_HEK293_Human | 1.96700624 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.96473648 |
| 26 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.92332336 |
| 27 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.89243793 |
| 28 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.86430420 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.85956633 |
| 30 | EWS_26573619_Chip-Seq_HEK293_Human | 1.85356501 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85159900 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.84017805 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.83029060 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.82321919 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.80050614 |
| 36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.79940558 |
| 37 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.78819350 |
| 38 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.78407214 |
| 39 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.75888981 |
| 40 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.74370931 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72858774 |
| 42 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.70323866 |
| 43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.68404644 |
| 44 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.61688732 |
| 45 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.61356016 |
| 46 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.61230472 |
| 47 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.61230472 |
| 48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.60780250 |
| 49 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.60578493 |
| 50 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.57537032 |
| 51 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.55977231 |
| 52 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.54879019 |
| 53 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.52832737 |
| 54 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.52011900 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50274033 |
| 56 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.49283127 |
| 57 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.48724692 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48110099 |
| 59 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.47707631 |
| 60 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.47474439 |
| 61 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.45955977 |
| 62 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.45330369 |
| 63 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.44461080 |
| 64 | AR_20517297_ChIP-Seq_VCAP_Human | 1.43775823 |
| 65 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.42579493 |
| 66 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.42579493 |
| 67 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.39676395 |
| 68 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.39413456 |
| 69 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.35844126 |
| 70 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.35560273 |
| 71 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.34747694 |
| 72 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.33778662 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33110060 |
| 74 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.32697208 |
| 75 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32017990 |
| 76 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.30702530 |
| 77 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.29795966 |
| 78 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.28321384 |
| 79 | NCOR_22424771_ChIP-Seq_293T_Human | 1.25656152 |
| 80 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.24334070 |
| 81 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.23323166 |
| 82 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21785723 |
| 83 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.21683746 |
| 84 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.21468048 |
| 85 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.21061775 |
| 86 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21041163 |
| 87 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20431683 |
| 88 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20402147 |
| 89 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19883695 |
| 90 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.19523073 |
| 91 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18942366 |
| 92 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.18614116 |
| 93 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.18351736 |
| 94 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.17873565 |
| 95 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.16896106 |
| 96 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.16740793 |
| 97 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.16622408 |
| 98 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.16401658 |
| 99 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15937077 |
| 100 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15126866 |
| 101 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.14634320 |
| 102 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.14124061 |
| 103 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13893847 |
| 104 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.13791210 |
| 105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13771594 |
| 106 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13693023 |
| 107 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.13367734 |
| 108 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.12357858 |
| 109 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12110521 |
| 110 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12026828 |
| 111 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11613116 |
| 112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11185465 |
| 113 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.10864795 |
| 114 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.10810305 |
| 115 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.10651630 |
| 116 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.09593879 |
| 117 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09010776 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.08996376 |
| 119 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.08949199 |
| 120 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.07897024 |
| 121 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.07441709 |
| 122 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.06307366 |
| 123 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05480827 |
| 124 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05126398 |
| 125 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.04690979 |
| 126 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.04294937 |
| 127 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.04091382 |
| 128 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.03968169 |
| 129 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.03494620 |
| 130 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.03467214 |
| 131 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.03267735 |
| 132 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02931504 |
| 133 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02377205 |
| 134 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02288895 |
| 135 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01327934 |
| 136 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.00214537 |
| 137 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99580950 |
| 138 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.99236483 |
| 139 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98913408 |
| 140 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.98616756 |
| 141 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.97348842 |
| 142 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.97224088 |
| 143 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96126069 |
| 144 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96126069 |
| 145 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.96074127 |
| 146 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.95889440 |
| 147 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95166532 |
| 148 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94890059 |
| 149 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.94850307 |
| 150 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.94432892 |
| 151 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94060369 |
| 152 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.93689069 |
| 153 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.92702418 |
| 154 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.91924742 |
| 155 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.91896500 |
| 156 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91832912 |
| 157 | TCF4_23295773_ChIP-Seq_U87_Human | 0.90431735 |
| 158 | KDM2B_26808549_Chip-Seq_REH_Human | 0.90234687 |
| 159 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.90005601 |
| 160 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.89529611 |
| 161 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.89529611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002735_abnormal_chemical_nociception | 5.86535394 |
| 2 | MP0004147_increased_porphyrin_level | 4.48944740 |
| 3 | MP0008875_abnormal_xenobiotic_pharmacok | 4.37984976 |
| 4 | MP0001986_abnormal_taste_sensitivity | 4.24756730 |
| 5 | MP0003646_muscle_fatigue | 3.90560812 |
| 6 | MP0006276_abnormal_autonomic_nervous | 3.30592284 |
| 7 | MP0003195_calcinosis | 3.17047103 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 3.15615686 |
| 9 | MP0004270_analgesia | 3.13303464 |
| 10 | MP0002736_abnormal_nociception_after | 2.82645467 |
| 11 | MP0001348_abnormal_lacrimal_gland | 2.78171986 |
| 12 | MP0009046_muscle_twitch | 2.77203032 |
| 13 | MP0004858_abnormal_nervous_system | 2.74172876 |
| 14 | MP0004043_abnormal_pH_regulation | 2.66761504 |
| 15 | MP0002102_abnormal_ear_morphology | 2.65991048 |
| 16 | MP0001968_abnormal_touch/_nociception | 2.65952316 |
| 17 | MP0002653_abnormal_ependyma_morphology | 2.65802738 |
| 18 | MP0000372_irregular_coat_pigmentation | 2.63709021 |
| 19 | MP0000751_myopathy | 2.53695510 |
| 20 | MP0001188_hyperpigmentation | 2.46358131 |
| 21 | MP0000749_muscle_degeneration | 2.38931888 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 2.32443551 |
| 23 | MP0002733_abnormal_thermal_nociception | 2.19816675 |
| 24 | MP0004145_abnormal_muscle_electrophysio | 2.15874973 |
| 25 | MP0005551_abnormal_eye_electrophysiolog | 2.11135238 |
| 26 | MP0004036_abnormal_muscle_relaxation | 2.03786620 |
| 27 | MP0004084_abnormal_cardiac_muscle | 2.02709503 |
| 28 | MP0004215_abnormal_myocardial_fiber | 2.01028296 |
| 29 | MP0001970_abnormal_pain_threshold | 1.97707646 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.96912258 |
| 31 | MP0005253_abnormal_eye_physiology | 1.89276545 |
| 32 | MP0004133_heterotaxia | 1.87010864 |
| 33 | MP0000015_abnormal_ear_pigmentation | 1.86316631 |
| 34 | MP0005171_absent_coat_pigmentation | 1.85974767 |
| 35 | MP0002272_abnormal_nervous_system | 1.85530747 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.83317486 |
| 37 | MP0002067_abnormal_sensory_capabilities | 1.79325367 |
| 38 | MP0008877_abnormal_DNA_methylation | 1.78966553 |
| 39 | MP0002751_abnormal_autonomic_nervous | 1.77536088 |
| 40 | MP0002972_abnormal_cardiac_muscle | 1.75188904 |
| 41 | MP0006072_abnormal_retinal_apoptosis | 1.74263393 |
| 42 | MP0008569_lethality_at_weaning | 1.73029561 |
| 43 | MP0002184_abnormal_innervation | 1.67820246 |
| 44 | MP0001529_abnormal_vocalization | 1.66627678 |
| 45 | MP0005645_abnormal_hypothalamus_physiol | 1.62870580 |
| 46 | MP0008872_abnormal_physiological_respon | 1.61458741 |
| 47 | MP0003828_pulmonary_edema | 1.59194680 |
| 48 | MP0002822_catalepsy | 1.57674999 |
| 49 | MP0008789_abnormal_olfactory_epithelium | 1.57398545 |
| 50 | MP0009379_abnormal_foot_pigmentation | 1.46676523 |
| 51 | MP0005423_abnormal_somatic_nervous | 1.46073471 |
| 52 | MP0004484_altered_response_of | 1.44310293 |
| 53 | MP0004885_abnormal_endolymph | 1.43703566 |
| 54 | MP0003137_abnormal_impulse_conducting | 1.42305277 |
| 55 | MP0003880_abnormal_central_pattern | 1.37533859 |
| 56 | MP0002132_abnormal_respiratory_system | 1.34855455 |
| 57 | MP0008775_abnormal_heart_ventricle | 1.33544538 |
| 58 | MP0004085_abnormal_heartbeat | 1.32091485 |
| 59 | MP0002106_abnormal_muscle_physiology | 1.30577541 |
| 60 | MP0000566_synostosis | 1.30089012 |
| 61 | MP0001544_abnormal_cardiovascular_syste | 1.27757876 |
| 62 | MP0005385_cardiovascular_system_phenoty | 1.27757876 |
| 63 | MP0005620_abnormal_muscle_contractility | 1.26701939 |
| 64 | MP0005365_abnormal_bile_salt | 1.26033137 |
| 65 | MP0003879_abnormal_hair_cell | 1.25563125 |
| 66 | MP0005330_cardiomyopathy | 1.23384075 |
| 67 | MP0008260_abnormal_autophagy | 1.23169862 |
| 68 | MP0000569_abnormal_digit_pigmentation | 1.22745114 |
| 69 | MP0001764_abnormal_homeostasis | 1.22435196 |
| 70 | MP0002148_abnormal_hypersensitivity_rea | 1.21894589 |
| 71 | MP0004142_abnormal_muscle_tone | 1.19933729 |
| 72 | MP0001765_abnormal_ion_homeostasis | 1.17544547 |
| 73 | MP0000383_abnormal_hair_follicle | 1.16844747 |
| 74 | MP0005409_darkened_coat_color | 1.16263166 |
| 75 | MP0004087_abnormal_muscle_fiber | 1.14752203 |
| 76 | MP0005332_abnormal_amino_acid | 1.13166878 |
| 77 | MP0005369_muscle_phenotype | 1.12337417 |
| 78 | MP0010678_abnormal_skin_adnexa | 1.11121269 |
| 79 | MP0005085_abnormal_gallbladder_physiolo | 1.10815069 |
| 80 | MP0005636_abnormal_mineral_homeostasis | 1.10700618 |
| 81 | MP0001502_abnormal_circadian_rhythm | 1.10438586 |
| 82 | MP0000759_abnormal_skeletal_muscle | 1.10125168 |
| 83 | MP0009745_abnormal_behavioral_response | 1.09809533 |
| 84 | MP0000427_abnormal_hair_cycle | 1.08696823 |
| 85 | MP0003635_abnormal_synaptic_transmissio | 1.08313723 |
| 86 | MP0004019_abnormal_vitamin_homeostasis | 1.08121712 |
| 87 | MP0002168_other_aberrant_phenotype | 1.07018870 |
| 88 | MP0000631_abnormal_neuroendocrine_gland | 1.06952240 |
| 89 | MP0005174_abnormal_tail_pigmentation | 1.06720119 |
| 90 | MP0002693_abnormal_pancreas_physiology | 1.06540289 |
| 91 | MP0004510_myositis | 1.06384639 |
| 92 | MP0001486_abnormal_startle_reflex | 1.06207214 |
| 93 | MP0001944_abnormal_pancreas_morphology | 1.04919626 |
| 94 | MP0002234_abnormal_pharynx_morphology | 1.04164152 |
| 95 | MP0003122_maternal_imprinting | 1.04032211 |
| 96 | MP0003136_yellow_coat_color | 1.03692654 |
| 97 | MP0000955_abnormal_spinal_cord | 1.03356862 |
| 98 | MP0005389_reproductive_system_phenotype | 1.02957382 |
| 99 | MP0001501_abnormal_sleep_pattern | 1.01818088 |
| 100 | MP0004859_abnormal_synaptic_plasticity | 1.01380182 |
| 101 | MP0002277_abnormal_respiratory_mucosa | 0.99304653 |
| 102 | MP0000516_abnormal_urinary_system | 0.98346010 |
| 103 | MP0005367_renal/urinary_system_phenotyp | 0.98346010 |
| 104 | MP0002928_abnormal_bile_duct | 0.98308158 |
| 105 | MP0002064_seizures | 0.97899256 |
| 106 | MP0003252_abnormal_bile_duct | 0.93840191 |
| 107 | MP0010329_abnormal_lipoprotein_level | 0.93626495 |
| 108 | MP0001756_abnormal_urination | 0.93602440 |
| 109 | MP0003698_abnormal_male_reproductive | 0.93574158 |
| 110 | MP0002876_abnormal_thyroid_physiology | 0.93246253 |
| 111 | MP0001905_abnormal_dopamine_level | 0.91799044 |
| 112 | MP0002229_neurodegeneration | 0.91325433 |
| 113 | MP0005220_abnormal_exocrine_pancreas | 0.91119623 |
| 114 | MP0005499_abnormal_olfactory_system | 0.90015706 |
| 115 | MP0005394_taste/olfaction_phenotype | 0.90015706 |
| 116 | MP0003806_abnormal_nucleotide_metabolis | 0.89299661 |
| 117 | MP0001929_abnormal_gametogenesis | 0.89197595 |
| 118 | MP0002078_abnormal_glucose_homeostasis | 0.86487650 |
| 119 | MP0002269_muscular_atrophy | 0.86218759 |
| 120 | MP0010234_abnormal_vibrissa_follicle | 0.85932161 |
| 121 | MP0005395_other_phenotype | 0.85488764 |
| 122 | MP0001963_abnormal_hearing_physiology | 0.84633557 |
| 123 | MP0001919_abnormal_reproductive_system | 0.82967815 |
| 124 | MP0004811_abnormal_neuron_physiology | 0.82670785 |
| 125 | MP0002572_abnormal_emotion/affect_behav | 0.82228313 |
| 126 | MP0005083_abnormal_biliary_tract | 0.81538037 |
| 127 | MP0008995_early_reproductive_senescence | 0.80640450 |
| 128 | MP0003718_maternal_effect | 0.79056110 |
| 129 | MP0003283_abnormal_digestive_organ | 0.78539202 |
| 130 | MP0006138_congestive_heart_failure | 0.76993773 |
| 131 | MP0002139_abnormal_hepatobiliary_system | 0.76849725 |
| 132 | MP0001835_abnormal_antigen_presentation | 0.76701688 |
| 133 | MP0000747_muscle_weakness | 0.74498782 |
| 134 | MP0005386_behavior/neurological_phenoty | 0.73487384 |
| 135 | MP0004924_abnormal_behavior | 0.73487384 |
| 136 | MP0005671_abnormal_response_to | 0.72594325 |
| 137 | MP0002909_abnormal_adrenal_gland | 0.70980971 |
| 138 | MP0001270_distended_abdomen | 0.70352649 |
| 139 | MP0002332_abnormal_exercise_endurance | 0.70194613 |
| 140 | MP0002063_abnormal_learning/memory/cond | 0.69214678 |
| 141 | MP0002095_abnormal_skin_pigmentation | 0.69213642 |
| 142 | MP0002752_abnormal_somatic_nervous | 0.68796614 |
| 143 | MP0002066_abnormal_motor_capabilities/c | 0.68094355 |
| 144 | MP0002882_abnormal_neuron_morphology | 0.66508104 |
| 145 | MP0005075_abnormal_melanosome_morpholog | 0.66089488 |
| 146 | MP0000343_altered_response_to | 0.65891285 |
| 147 | MP0003183_abnormal_peptide_metabolism | 0.65482158 |
| 148 | MP0004883_abnormal_blood_vessel | 0.64679660 |
| 149 | MP0004381_abnormal_hair_follicle | 0.64638807 |
| 150 | MP0001485_abnormal_pinna_reflex | 0.63695474 |
| 151 | MP0002160_abnormal_reproductive_system | 0.62065675 |
| 152 | MP0003787_abnormal_imprinting | 0.61775961 |
| 153 | MP0010630_abnormal_cardiac_muscle | 0.61037366 |
| 154 | MP0001984_abnormal_olfaction | 0.60943331 |
| 155 | MP0002638_abnormal_pupillary_reflex | 0.60296657 |
| 156 | MP0004742_abnormal_vestibular_system | 0.60257842 |
| 157 | MP0003329_amyloid_beta_deposits | 0.59928150 |
| 158 | MP0002557_abnormal_social/conspecific_i | 0.58717685 |
| 159 | MP0009764_decreased_sensitivity_to | 0.58450279 |
| 160 | MP0001542_abnormal_bone_strength | 0.58352547 |
| 161 | MP0006036_abnormal_mitochondrial_physio | 0.58237419 |
| 162 | MP0009697_abnormal_copulation | 0.57137420 |
| 163 | MP0000750_abnormal_muscle_regeneration | 0.55774094 |
| 164 | MP0000026_abnormal_inner_ear | 0.55542820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 7.30864054 |
| 2 | Absent/shortened dynein arms (HP:0200106) | 7.30864054 |
| 3 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 7.23176651 |
| 4 | Abnormal respiratory motile cilium morphology (HP:0005938) | 7.17781899 |
| 5 | Abnormal respiratory epithelium morphology (HP:0012253) | 7.17781899 |
| 6 | Abnormal ciliary motility (HP:0012262) | 6.76529298 |
| 7 | Ulnar claw (HP:0001178) | 6.74167668 |
| 8 | Abnormal respiratory motile cilium physiology (HP:0012261) | 6.63310370 |
| 9 | Rhinitis (HP:0012384) | 6.03484154 |
| 10 | Febrile seizures (HP:0002373) | 5.37383705 |
| 11 | Hypothermia (HP:0002045) | 4.63935150 |
| 12 | Chronic bronchitis (HP:0004469) | 4.56826438 |
| 13 | Distal lower limb muscle weakness (HP:0009053) | 4.38335081 |
| 14 | Bronchiectasis (HP:0002110) | 4.37725383 |
| 15 | Myokymia (HP:0002411) | 4.29964505 |
| 16 | Focal motor seizures (HP:0011153) | 4.19245838 |
| 17 | Action tremor (HP:0002345) | 4.18236309 |
| 18 | Areflexia of lower limbs (HP:0002522) | 4.17243587 |
| 19 | True hermaphroditism (HP:0010459) | 4.07408619 |
| 20 | Pancreatic fibrosis (HP:0100732) | 4.07160616 |
| 21 | Pancreatic cysts (HP:0001737) | 4.02145488 |
| 22 | Calf muscle hypertrophy (HP:0008981) | 3.97691821 |
| 23 | Sudden death (HP:0001699) | 3.94265704 |
| 24 | Atrial fibrillation (HP:0005110) | 3.84074074 |
| 25 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.80455333 |
| 26 | Molar tooth sign on MRI (HP:0002419) | 3.78894916 |
| 27 | Abnormality of midbrain morphology (HP:0002418) | 3.78894916 |
| 28 | Nephronophthisis (HP:0000090) | 3.69381462 |
| 29 | Myotonia (HP:0002486) | 3.60769019 |
| 30 | Foot dorsiflexor weakness (HP:0009027) | 3.60708451 |
| 31 | Hyporeflexia of lower limbs (HP:0002600) | 3.57291366 |
| 32 | Primary atrial arrhythmia (HP:0001692) | 3.54503065 |
| 33 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.51956803 |
| 34 | Steppage gait (HP:0003376) | 3.51462767 |
| 35 | Supraventricular tachycardia (HP:0004755) | 3.41321576 |
| 36 | Ventricular fibrillation (HP:0001663) | 3.41110043 |
| 37 | Bradycardia (HP:0001662) | 3.40660511 |
| 38 | Chronic hepatic failure (HP:0100626) | 3.33800897 |
| 39 | Ventricular tachycardia (HP:0004756) | 3.31969724 |
| 40 | Nasal polyposis (HP:0100582) | 3.27915061 |
| 41 | Prolonged QT interval (HP:0001657) | 3.27406261 |
| 42 | Supraventricular arrhythmia (HP:0005115) | 3.27341036 |
| 43 | Atonic seizures (HP:0010819) | 3.26172685 |
| 44 | Abnormality of the foot musculature (HP:0001436) | 3.26086656 |
| 45 | Fetal akinesia sequence (HP:0001989) | 3.20064705 |
| 46 | Pheochromocytoma (HP:0002666) | 3.16097229 |
| 47 | Abnormality of the renal medulla (HP:0100957) | 3.15954565 |
| 48 | Cystic liver disease (HP:0006706) | 3.12824006 |
| 49 | Neuroendocrine neoplasm (HP:0100634) | 3.09466094 |
| 50 | Palpitations (HP:0001962) | 3.02607991 |
| 51 | Occipital encephalocele (HP:0002085) | 2.97914306 |
| 52 | Medial flaring of the eyebrow (HP:0010747) | 2.96821064 |
| 53 | Abnormality of the calf musculature (HP:0001430) | 2.95914731 |
| 54 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.93305808 |
| 55 | Bundle branch block (HP:0011710) | 2.91600928 |
| 56 | Submucous cleft hard palate (HP:0000176) | 2.81917748 |
| 57 | Exercise-induced myalgia (HP:0003738) | 2.80098412 |
| 58 | Muscle fiber splitting (HP:0003555) | 2.75334174 |
| 59 | Heart block (HP:0012722) | 2.70780033 |
| 60 | Syncope (HP:0001279) | 2.69169516 |
| 61 | EMG: myopathic abnormalities (HP:0003458) | 2.67734377 |
| 62 | Chronic sinusitis (HP:0011109) | 2.64694188 |
| 63 | Lipoatrophy (HP:0100578) | 2.62860352 |
| 64 | Subaortic stenosis (HP:0001682) | 2.61861858 |
| 65 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.61861858 |
| 66 | Exercise-induced muscle cramps (HP:0003710) | 2.60873101 |
| 67 | Abnormal atrioventricular conduction (HP:0005150) | 2.60825073 |
| 68 | Muscle stiffness (HP:0003552) | 2.60596161 |
| 69 | Tubular atrophy (HP:0000092) | 2.60550144 |
| 70 | Progressive cerebellar ataxia (HP:0002073) | 2.58711844 |
| 71 | Abnormal EKG (HP:0003115) | 2.57275776 |
| 72 | Ketoacidosis (HP:0001993) | 2.49430842 |
| 73 | Acute necrotizing encephalopathy (HP:0006965) | 2.44609288 |
| 74 | Attenuation of retinal blood vessels (HP:0007843) | 2.44038835 |
| 75 | Infertility (HP:0000789) | 2.42178535 |
| 76 | Recurrent sinusitis (HP:0011108) | 2.40834871 |
| 77 | Abnormality of the renal cortex (HP:0011035) | 2.40368391 |
| 78 | Congenital stationary night blindness (HP:0007642) | 2.40360956 |
| 79 | Postaxial foot polydactyly (HP:0001830) | 2.40262656 |
| 80 | Abnormality of the nasal mucosa (HP:0000433) | 2.39807924 |
| 81 | Abnormal drinking behavior (HP:0030082) | 2.37219914 |
| 82 | Polydipsia (HP:0001959) | 2.37219914 |
| 83 | Hepatocellular necrosis (HP:0001404) | 2.37012700 |
| 84 | Distal arthrogryposis (HP:0005684) | 2.35170751 |
| 85 | Mitochondrial inheritance (HP:0001427) | 2.32393208 |
| 86 | Congenital primary aphakia (HP:0007707) | 2.31724403 |
| 87 | Gait imbalance (HP:0002141) | 2.31499303 |
| 88 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.30505287 |
| 89 | Congenital hepatic fibrosis (HP:0002612) | 2.28928765 |
| 90 | Abnormality of alanine metabolism (HP:0010916) | 2.28854201 |
| 91 | Hyperalaninemia (HP:0003348) | 2.28854201 |
| 92 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.28854201 |
| 93 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.28333242 |
| 94 | Male pseudohermaphroditism (HP:0000037) | 2.26347943 |
| 95 | Left ventricular hypertrophy (HP:0001712) | 2.25701766 |
| 96 | Focal seizures (HP:0007359) | 2.24808149 |
| 97 | Impaired pain sensation (HP:0007328) | 2.24229150 |
| 98 | Abnormality of pain sensation (HP:0010832) | 2.24229150 |
| 99 | Bronchitis (HP:0012387) | 2.23869144 |
| 100 | Gaze-evoked nystagmus (HP:0000640) | 2.22441904 |
| 101 | Hepatic necrosis (HP:0002605) | 2.21856228 |
| 102 | Decreased central vision (HP:0007663) | 2.19844773 |
| 103 | Decreased motor nerve conduction velocity (HP:0003431) | 2.19390347 |
| 104 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.18653804 |
| 105 | Decreased circulating renin level (HP:0003351) | 2.18262144 |
| 106 | Atrioventricular block (HP:0001678) | 2.17639265 |
| 107 | Hyperactive renin-angiotensin system (HP:0000841) | 2.16209538 |
| 108 | Nephrogenic diabetes insipidus (HP:0009806) | 2.14387348 |
| 109 | Type II lissencephaly (HP:0007260) | 2.13804096 |
| 110 | Furrowed tongue (HP:0000221) | 2.13198524 |
| 111 | Dilated cardiomyopathy (HP:0001644) | 2.12164861 |
| 112 | Tubulointerstitial nephritis (HP:0001970) | 2.12055382 |
| 113 | Sclerocornea (HP:0000647) | 2.11826734 |
| 114 | Absent speech (HP:0001344) | 2.09461625 |
| 115 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.08554356 |
| 116 | Increased CSF lactate (HP:0002490) | 2.06997888 |
| 117 | Generalized tonic-clonic seizures (HP:0002069) | 2.06398749 |
| 118 | Autoamputation (HP:0001218) | 2.03524053 |
| 119 | Progressive macrocephaly (HP:0004481) | 2.03186525 |
| 120 | Abnormal hair whorl (HP:0010721) | 2.02674014 |
| 121 | Hyperkalemia (HP:0002153) | 2.02264279 |
| 122 | Postaxial hand polydactyly (HP:0001162) | 2.01716665 |
| 123 | Polyuria (HP:0000103) | 2.01706617 |
| 124 | Hypokalemic alkalosis (HP:0001949) | 2.00137578 |
| 125 | Anencephaly (HP:0002323) | 1.99193641 |
| 126 | Muscle fiber inclusion bodies (HP:0100299) | 1.98860097 |
| 127 | Ventricular arrhythmia (HP:0004308) | 1.97736655 |
| 128 | Absence seizures (HP:0002121) | 1.97213381 |
| 129 | Epileptic encephalopathy (HP:0200134) | 1.95806485 |
| 130 | Tinnitus (HP:0000360) | 1.95549939 |
| 131 | Methylmalonic acidemia (HP:0002912) | 1.95418867 |
| 132 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.94886979 |
| 133 | Right ventricular cardiomyopathy (HP:0011663) | 1.94293233 |
| 134 | Large for gestational age (HP:0001520) | 1.93254356 |
| 135 | Abolished electroretinogram (ERG) (HP:0000550) | 1.93131741 |
| 136 | Abnormality of renin-angiotensin system (HP:0000847) | 1.91719577 |
| 137 | Impaired proprioception (HP:0010831) | 1.89861205 |
| 138 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.89545712 |
| 139 | Ketosis (HP:0001946) | 1.88472801 |
| 140 | Prostate neoplasm (HP:0100787) | 1.88138466 |
| 141 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.87954613 |
| 142 | Onion bulb formation (HP:0003383) | 1.87486747 |
| 143 | Renal salt wasting (HP:0000127) | 1.84900677 |
| 144 | Slow saccadic eye movements (HP:0000514) | 1.84100176 |
| 145 | Abnormal biliary tract physiology (HP:0012439) | 1.83741317 |
| 146 | Bile duct proliferation (HP:0001408) | 1.83741317 |
| 147 | Abnormality of the vocal cords (HP:0008777) | 1.83450953 |
| 148 | Distal sensory impairment (HP:0002936) | 1.83255018 |
| 149 | Distal lower limb amyotrophy (HP:0008944) | 1.83026991 |
| 150 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.82977212 |
| 151 | Hammertoe (HP:0001765) | 1.82108332 |
| 152 | Mask-like facies (HP:0000298) | 1.81636855 |
| 153 | Hypercortisolism (HP:0001578) | 1.80984052 |
| 154 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.80954092 |
| 155 | Nemaline bodies (HP:0003798) | 1.80286037 |
| 156 | Recurrent abscess formation (HP:0002722) | 1.79986200 |
| 157 | Lactic acidosis (HP:0003128) | 1.79744493 |
| 158 | Failure to thrive in infancy (HP:0001531) | 1.79053119 |
| 159 | Supranuclear gaze palsy (HP:0000605) | 1.79043300 |
| 160 | Asymmetric septal hypertrophy (HP:0001670) | 1.78174436 |
| 161 | Optic nerve hypoplasia (HP:0000609) | 1.77135206 |
| 162 | Chronic otitis media (HP:0000389) | 1.75752375 |
| 163 | Thyroid carcinoma (HP:0002890) | 1.74827870 |
| 164 | Hypomagnesemia (HP:0002917) | 1.74793054 |
| 165 | Myoglobinuria (HP:0002913) | 1.74323581 |
| 166 | Male infertility (HP:0003251) | 1.73104131 |
| 167 | Hyperaldosteronism (HP:0000859) | 1.72909762 |
| 168 | Ankle clonus (HP:0011448) | 1.72804335 |
| 169 | Dialeptic seizures (HP:0011146) | 1.72653493 |
| 170 | EMG: neuropathic changes (HP:0003445) | 1.72160449 |
| 171 | Abnormality of chloride homeostasis (HP:0011422) | 1.71287954 |
| 172 | Asplenia (HP:0001746) | 1.69610008 |
| 173 | Recurrent otitis media (HP:0000403) | 1.68107929 |
| 174 | Oculomotor apraxia (HP:0000657) | 1.66000262 |
| 175 | Methylmalonic aciduria (HP:0012120) | 1.63457891 |
| 176 | Abnormal urine output (HP:0012590) | 1.63444865 |
| 177 | Genital tract atresia (HP:0001827) | 1.62958989 |
| 178 | Abnormality of macular pigmentation (HP:0008002) | 1.57887552 |
| 179 | Retinitis pigmentosa (HP:0000510) | 1.57529669 |
| 180 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.57061216 |
| 181 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.57061216 |
| 182 | Vaginal atresia (HP:0000148) | 1.57004097 |
| 183 | Abnormality of renal excretion (HP:0011036) | 1.56396780 |
| 184 | Hemiparesis (HP:0001269) | 1.55096219 |
| 185 | Hyperglycemia (HP:0003074) | 1.54831067 |
| 186 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.54159585 |
| 187 | Retinal dysplasia (HP:0007973) | 1.53222600 |
| 188 | Tubulointerstitial abnormality (HP:0001969) | 1.50808050 |
| 189 | Constricted visual fields (HP:0001133) | 1.50626431 |
| 190 | Dyschromatopsia (HP:0007641) | 1.48267780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.51188688 |
| 2 | LMTK2 | 4.05350146 |
| 3 | CASK | 4.00750092 |
| 4 | MAPK15 | 3.85315370 |
| 5 | MAP4K2 | 3.34618335 |
| 6 | NTRK3 | 3.17779361 |
| 7 | MAPKAPK3 | 2.94921060 |
| 8 | TRIM28 | 2.80394707 |
| 9 | NEK9 | 2.71247115 |
| 10 | MINK1 | 2.65527389 |
| 11 | PHKG2 | 2.63203488 |
| 12 | PHKG1 | 2.63203488 |
| 13 | SIK3 | 2.44535364 |
| 14 | PINK1 | 2.32434885 |
| 15 | GRK7 | 2.26616190 |
| 16 | MAP2K7 | 2.24936619 |
| 17 | WNK3 | 2.22374422 |
| 18 | BCR | 2.15749230 |
| 19 | SGK2 | 1.97551434 |
| 20 | MAP3K12 | 1.97253293 |
| 21 | STK24 | 1.95626766 |
| 22 | MAP3K14 | 1.93145414 |
| 23 | MUSK | 1.92809748 |
| 24 | MATK | 1.88561899 |
| 25 | GRK1 | 1.87876491 |
| 26 | ZAK | 1.80680443 |
| 27 | WNK1 | 1.73644952 |
| 28 | EPHA3 | 1.67908537 |
| 29 | OXSR1 | 1.66682643 |
| 30 | EPHA4 | 1.64277153 |
| 31 | EIF2AK3 | 1.61370731 |
| 32 | MAPK13 | 1.60425840 |
| 33 | YES1 | 1.53913415 |
| 34 | NTRK1 | 1.51751368 |
| 35 | NUAK1 | 1.47663348 |
| 36 | OBSCN | 1.47381416 |
| 37 | SGK223 | 1.30511002 |
| 38 | SGK494 | 1.30511002 |
| 39 | TLK1 | 1.30138008 |
| 40 | SGK3 | 1.30030174 |
| 41 | IRAK4 | 1.28214939 |
| 42 | NME1 | 1.24675856 |
| 43 | CAMKK2 | 1.23873266 |
| 44 | FGFR2 | 1.23042895 |
| 45 | PLK2 | 1.22278859 |
| 46 | STK39 | 1.21913521 |
| 47 | PAK3 | 1.20935451 |
| 48 | MAP3K11 | 1.20556181 |
| 49 | IRAK3 | 1.20544293 |
| 50 | TXK | 1.18136132 |
| 51 | PRPF4B | 1.17482617 |
| 52 | CSNK1G3 | 1.12151391 |
| 53 | RPS6KA2 | 1.10931122 |
| 54 | TTN | 1.05620822 |
| 55 | TNK2 | 1.05475502 |
| 56 | BLK | 1.05132365 |
| 57 | DAPK2 | 1.04561677 |
| 58 | ACVR1B | 1.04422941 |
| 59 | CSNK1A1L | 1.04087310 |
| 60 | ADRBK2 | 1.03871419 |
| 61 | CSNK1G2 | 1.03120198 |
| 62 | BMPR2 | 1.01214302 |
| 63 | CSNK1G1 | 1.00255039 |
| 64 | TIE1 | 1.00163505 |
| 65 | MAP2K4 | 0.99725245 |
| 66 | TRPM7 | 0.99711288 |
| 67 | DYRK2 | 0.99699931 |
| 68 | EIF2AK1 | 0.99434503 |
| 69 | MAP3K7 | 0.97794415 |
| 70 | MYLK | 0.95552503 |
| 71 | RPS6KL1 | 0.91407855 |
| 72 | RPS6KC1 | 0.91407855 |
| 73 | EPHA2 | 0.86915119 |
| 74 | AKT3 | 0.86078506 |
| 75 | PIM2 | 0.83369608 |
| 76 | TEC | 0.82859222 |
| 77 | PTK2B | 0.82121449 |
| 78 | BRSK2 | 0.81900966 |
| 79 | RPS6KA6 | 0.80962597 |
| 80 | CCNB1 | 0.80102852 |
| 81 | BCKDK | 0.79791474 |
| 82 | PRKCI | 0.79642906 |
| 83 | TNIK | 0.79232036 |
| 84 | NLK | 0.77459010 |
| 85 | BMPR1B | 0.75210866 |
| 86 | LATS2 | 0.73610727 |
| 87 | MARK1 | 0.73358022 |
| 88 | PRKAA2 | 0.70662208 |
| 89 | MAP3K4 | 0.70419317 |
| 90 | PRKCE | 0.70404745 |
| 91 | ADRBK1 | 0.68626566 |
| 92 | CAMK2G | 0.68474834 |
| 93 | FER | 0.68313835 |
| 94 | PLK3 | 0.67589817 |
| 95 | STK38L | 0.67070622 |
| 96 | ARAF | 0.67001212 |
| 97 | MST4 | 0.66883735 |
| 98 | INSRR | 0.66579687 |
| 99 | IRAK1 | 0.62363903 |
| 100 | MAP4K1 | 0.62171393 |
| 101 | MAP2K6 | 0.60235920 |
| 102 | MAP3K1 | 0.59868608 |
| 103 | JAK1 | 0.59078149 |
| 104 | PRKCG | 0.59033771 |
| 105 | PRKAA1 | 0.56798637 |
| 106 | CAMK2D | 0.56026129 |
| 107 | BRAF | 0.55026768 |
| 108 | SYK | 0.54942880 |
| 109 | NEK1 | 0.54607390 |
| 110 | VRK1 | 0.54079288 |
| 111 | LATS1 | 0.53848220 |
| 112 | ERBB3 | 0.53766185 |
| 113 | SCYL2 | 0.53529652 |
| 114 | EPHB1 | 0.51757743 |
| 115 | CAMK2A | 0.50826639 |
| 116 | IRAK2 | 0.50513833 |
| 117 | LIMK1 | 0.49768417 |
| 118 | CDK19 | 0.49388980 |
| 119 | PKN1 | 0.48185012 |
| 120 | EIF2AK2 | 0.48114229 |
| 121 | STK11 | 0.47705417 |
| 122 | WNK4 | 0.47304923 |
| 123 | CSNK1A1 | 0.46008438 |
| 124 | HIPK2 | 0.45376736 |
| 125 | DMPK | 0.44613448 |
| 126 | TAOK3 | 0.44440140 |
| 127 | CAMK1 | 0.43787868 |
| 128 | PRKACA | 0.43421349 |
| 129 | MAP2K1 | 0.42581833 |
| 130 | MAP2K3 | 0.41541185 |
| 131 | PLK1 | 0.41399951 |
| 132 | PRKACB | 0.41300925 |
| 133 | MARK3 | 0.39841420 |
| 134 | MAP3K2 | 0.39215534 |
| 135 | CDC42BPA | 0.38421912 |
| 136 | IKBKE | 0.38080344 |
| 137 | CSNK1D | 0.37397898 |
| 138 | STK3 | 0.37182645 |
| 139 | RPS6KB1 | 0.36570975 |
| 140 | FGFR3 | 0.35298335 |
| 141 | MKNK2 | 0.35181813 |
| 142 | RIPK4 | 0.34696833 |
| 143 | ROCK2 | 0.34410957 |
| 144 | PRKG1 | 0.34338440 |
| 145 | PIK3CA | 0.34206539 |
| 146 | PRKCH | 0.33954165 |
| 147 | PDK3 | 0.33124451 |
| 148 | PDK4 | 0.33124451 |
| 149 | GRK5 | 0.31375317 |
| 150 | ROCK1 | 0.30223168 |
| 151 | STK38 | 0.29809087 |
| 152 | PRKCQ | 0.29410998 |
| 153 | PRKCA | 0.28869562 |
| 154 | MAPKAPK5 | 0.28645547 |
| 155 | WEE1 | 0.24469623 |
| 156 | TTK | 0.23164924 |
| 157 | NEK6 | 0.21103166 |
| 158 | CDK5 | 0.20774151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.33458745 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.99263366 |
| 3 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 2.97189275 |
| 4 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.55876858 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.50798185 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.49560722 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.36370637 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.34710260 |
| 9 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.26334765 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.24984699 |
| 11 | Taste transduction_Homo sapiens_hsa04742 | 2.20634604 |
| 12 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.17780153 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.12473932 |
| 14 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.12062879 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.10830268 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08334392 |
| 17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.06897165 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.05612530 |
| 19 | Phototransduction_Homo sapiens_hsa04744 | 2.04122163 |
| 20 | Protein export_Homo sapiens_hsa03060 | 2.00424159 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00244809 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.99048457 |
| 23 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.91264318 |
| 24 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.90645396 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.90604158 |
| 26 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.85895260 |
| 27 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.85653036 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.84955779 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.83132785 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.78178734 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.70681151 |
| 32 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.70498295 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.69243241 |
| 34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.67018147 |
| 35 | Nicotine addiction_Homo sapiens_hsa05033 | 1.59422163 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54939458 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.54088415 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.49855235 |
| 39 | Huntingtons disease_Homo sapiens_hsa05016 | 1.49395098 |
| 40 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.48586640 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45624901 |
| 42 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.45508985 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.45475855 |
| 44 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.44799040 |
| 45 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.41665176 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.38466496 |
| 47 | Circadian entrainment_Homo sapiens_hsa04713 | 1.38449433 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.38128506 |
| 49 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.36682714 |
| 50 | Circadian rhythm_Homo sapiens_hsa04710 | 1.34784965 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.34151526 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31739234 |
| 53 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.31528692 |
| 54 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.26892807 |
| 55 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.26123764 |
| 56 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.24934732 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 1.24486272 |
| 58 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.24067780 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.24037541 |
| 60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.23141955 |
| 61 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.17797230 |
| 62 | Insulin secretion_Homo sapiens_hsa04911 | 1.13127379 |
| 63 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.12316815 |
| 64 | Phagosome_Homo sapiens_hsa04145 | 1.11191977 |
| 65 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07870682 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07637044 |
| 67 | Proteasome_Homo sapiens_hsa03050 | 1.05353734 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.05060424 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04360044 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03052376 |
| 71 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.00329897 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.97533520 |
| 73 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.96676427 |
| 74 | Long-term potentiation_Homo sapiens_hsa04720 | 0.96113141 |
| 75 | Morphine addiction_Homo sapiens_hsa05032 | 0.94331712 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93688885 |
| 77 | Leishmaniasis_Homo sapiens_hsa05140 | 0.93234236 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.92479147 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91939699 |
| 80 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.90669555 |
| 81 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.90445942 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90193272 |
| 83 | Basal transcription factors_Homo sapiens_hsa03022 | 0.89715969 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.88207027 |
| 85 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.86977040 |
| 86 | Allograft rejection_Homo sapiens_hsa05330 | 0.85831895 |
| 87 | Melanoma_Homo sapiens_hsa05218 | 0.85815872 |
| 88 | Salivary secretion_Homo sapiens_hsa04970 | 0.85272561 |
| 89 | Tuberculosis_Homo sapiens_hsa05152 | 0.85198110 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84315729 |
| 91 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.83969679 |
| 92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81896027 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.80974295 |
| 94 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.80476456 |
| 95 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.76722250 |
| 96 | Renin secretion_Homo sapiens_hsa04924 | 0.76383077 |
| 97 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.75041501 |
| 98 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.75019154 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73748718 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73271602 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72290372 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70081578 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69618243 |
| 104 | Measles_Homo sapiens_hsa05162 | 0.69199641 |
| 105 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.68927689 |
| 106 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68490379 |
| 107 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67683051 |
| 108 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65188970 |
| 109 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.64632197 |
| 110 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.63720378 |
| 111 | Long-term depression_Homo sapiens_hsa04730 | 0.63382866 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63228097 |
| 113 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62871175 |
| 114 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62429190 |
| 115 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.62363946 |
| 116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.61802632 |
| 117 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.60894910 |
| 118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.59192357 |
| 119 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58632935 |
| 120 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.58518271 |
| 121 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57800537 |
| 122 | Asthma_Homo sapiens_hsa05310 | 0.57344107 |
| 123 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.56979843 |
| 124 | GABAergic synapse_Homo sapiens_hsa04727 | 0.56876726 |
| 125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56628404 |
| 126 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56249911 |
| 127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55549476 |
| 128 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54416598 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54070622 |
| 130 | Platelet activation_Homo sapiens_hsa04611 | 0.52998229 |
| 131 | RNA degradation_Homo sapiens_hsa03018 | 0.52182681 |
| 132 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51945321 |
| 133 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51227639 |
| 134 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.50489031 |
| 135 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.49997273 |
| 136 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49893130 |
| 137 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49665627 |
| 138 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49654019 |
| 139 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.49587998 |
| 140 | Apoptosis_Homo sapiens_hsa04210 | 0.49237226 |
| 141 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.49132257 |
| 142 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49061283 |
| 143 | Homologous recombination_Homo sapiens_hsa03440 | 0.48945691 |
| 144 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48586275 |
| 145 | Pertussis_Homo sapiens_hsa05133 | 0.48362296 |
| 146 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.46832172 |
| 147 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.46760647 |
| 148 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.46462540 |
| 149 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46222291 |
| 150 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.45991627 |
| 151 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45790628 |
| 152 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44260600 |
| 153 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.43322803 |
| 154 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43271409 |
| 155 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43181036 |
| 156 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42832619 |
| 157 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.42831913 |
| 158 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42696209 |
| 159 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42209819 |
| 160 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42148953 |
| 161 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.41983603 |
| 162 | Influenza A_Homo sapiens_hsa05164 | 0.41622069 |
| 163 | Purine metabolism_Homo sapiens_hsa00230 | 0.40372372 |
| 164 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39692602 |
| 165 | Cocaine addiction_Homo sapiens_hsa05030 | 0.37377420 |
| 166 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.36432134 |

